Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
Abstract Background Treatment of moderate to severe Graves’ orbitopathy (GO) is based mainly on intravenous pulses of methylprednisolone. High doses of methylprednisolone can exert several adverse effects, some of which might be life-threatening. The objective of this study is to describe the most s...
Main Authors: | Dorota Walasik-Szemplińska, Grzegorz Kamiński, Iwona Sudoł-Szopińska |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Thyroid Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13044-019-0074-0 |
Similar Items
-
Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves′ orbitopathy: A randomized controlled trial
by: Ajitesh Roy, et al.
Published: (2015-01-01) -
Success Treatment of Severe and Active Graves’ Orbitopathy with Tocilizumab After Thyroidectomy and Maximum Dose of Intravenous Methylprednisolone
by: Laurentius Aswin Pramono
Published: (2023-10-01) -
Adipocytokines in Graves’ orbitopathy and the effect of high-dose corticosteroids
by: Jan Schovanek, et al.
Published: (2021-01-01) -
Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Joanna Rymuza, et al.
Published: (2022-08-01) -
Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate
by: Katarzyna Pelewicz, et al.
Published: (2020-10-01)